Neuronetics (STIM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.88, -3.33% vs the prior close of $1.95.
- Volume 967.69K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
STIM slides 3.3% to $1.88. Closed at $1.88, -3.33% vs the prior close of $1.95. Day range $1.85–$1.97, opened at $1.95.
STIM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — STIM slides 3.3% to $1.88
- Closed at $1.88, -3.33% vs the prior close of $1.95. Day range $1.85–$1.97, opened at $1.95.
- Volume was 967.69K shares, 0.5x its 50-day average of 1.83M — lighter than usual.
- Price is -30.0% vs its 50-day average ($2.69) and +1.8% vs its 200-day average ($1.85).
- 52-week range $0.80–$3.44; today's close sits at 41% of that range, 45.2% below the 52-week high.
Oct 15, 2026 — STIM jumps 3.4% to $1.95
- Closed at $1.95, +3.45% vs the prior close of $1.88. Day range $1.84–$1.99, opened at $1.88.
- Volume was 768.60K shares, 0.4x its 50-day average of 1.84M — lighter than usual.
- Price is -27.8% vs its 50-day average ($2.70) and +5.4% vs its 200-day average ($1.85).
- 52-week range $0.80–$3.44; today's close sits at 44% of that range, 43.3% below the 52-week high.
Oct 14, 2026 — STIM slides 5.3% to $1.88, a 1-month low, 6 down days in a row
- Closed at $1.88, -5.28% vs the prior close of $1.99. Day range $1.88–$1.97, opened at $1.95.
- Volume was 818.20K shares, 0.4x its 50-day average of 1.87M — lighter than usual.
- Price is -30.4% vs its 50-day average ($2.71) and +2.1% vs its 200-day average ($1.85).
- 52-week range $0.80–$3.44; today's close sits at 41% of that range, 45.2% below the 52-week high.
- That makes 6 straight losses.
Oct 13, 2026 — STIM slides 6.6% to $1.99, a 1-month low, 5 down days in a row
- Closed at $1.99, -6.57% vs the prior close of $2.13. Day range $1.99–$2.13, opened at $2.13.
- Volume was 547.90K shares, 0.3x its 50-day average of 1.88M — lighter than usual.
- Price is -26.7% vs its 50-day average ($2.72) and +7.9% vs its 200-day average ($1.84).
- 52-week range $0.80–$3.44; today's close sits at 45% of that range, 42.2% below the 52-week high.
- That makes 5 straight losses.
Oct 12, 2026 — STIM ends flat (+0.0%) to $2.13, 4 down days in a row
- Closed at $2.13, +0.00% vs the prior close of $2.13. Day range $2.10–$2.14, opened at $2.13.
- Volume was 329.70K shares, 0.2x its 50-day average of 1.90M — lighter than usual.
- Price is -21.7% vs its 50-day average ($2.72) and +15.6% vs its 200-day average ($1.84).
- 52-week range $0.80–$3.44; today's close sits at 50% of that range, 38.1% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — STIM dips 0.5% to $2.13, a 1-month low, 3 down days in a row
- Closed at $2.13, -0.47% vs the prior close of $2.14. Day range $2.11–$2.20, opened at $2.14.
- Volume was 578.70K shares, 0.3x its 50-day average of 1.90M — lighter than usual.
- Price is -21.6% vs its 50-day average ($2.72) and +15.9% vs its 200-day average ($1.84).
- 52-week range $0.80–$3.44; today's close sits at 50% of that range, 38.1% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — STIM dips 1.4% to $2.14, a 1-month low
- Closed at $2.14, -1.38% vs the prior close of $2.17. Day range $2.11–$2.19, opened at $2.19.
- Volume was 646.90K shares, 0.3x its 50-day average of 1.92M — lighter than usual.
- Price is -21.1% vs its 50-day average ($2.71) and +16.6% vs its 200-day average ($1.84).
- 52-week range $0.80–$3.44; today's close sits at 51% of that range, 37.8% below the 52-week high.
Oct 7, 2026 — STIM dips 1.8% to $2.17
- Closed at $2.17, -1.81% vs the prior close of $2.21. Day range $2.15–$2.22, opened at $2.21.
- Volume was 641.90K shares, 0.3x its 50-day average of 1.92M — lighter than usual.
- Price is -19.8% vs its 50-day average ($2.71) and +18.5% vs its 200-day average ($1.83).
- 52-week range $0.80–$3.44; today's close sits at 52% of that range, 36.9% below the 52-week high.
Oct 6, 2026 — STIM rises 0.5% to $2.21
- Closed at $2.21, +0.45% vs the prior close of $2.20. Day range $2.19–$2.28, opened at $2.22.
- Volume was 771.80K shares, 0.4x its 50-day average of 1.92M — lighter than usual.
- Price is -18.2% vs its 50-day average ($2.70) and +20.9% vs its 200-day average ($1.83).
- 52-week range $0.80–$3.44; today's close sits at 53% of that range, 35.8% below the 52-week high.
Oct 5, 2026 — STIM rises 1.9% to $2.20
- Closed at $2.20, +1.85% vs the prior close of $2.16. Day range $2.12–$2.28, opened at $2.14.
- Volume was 810.30K shares, 0.4x its 50-day average of 1.93M — lighter than usual.
- Price is -18.3% vs its 50-day average ($2.69) and +20.6% vs its 200-day average ($1.82).
- 52-week range $0.80–$3.44; today's close sits at 53% of that range, 36.0% below the 52-week high.
Oct 2, 2026 — STIM dips 2.7% to $2.16, a 1-month low, 8 down days in a row
- Closed at $2.16, -2.70% vs the prior close of $2.22. Day range $2.12–$2.26, opened at $2.23.
- Volume was 1.27M shares, 0.7x its 50-day average of 1.92M.
- Price is -19.5% vs its 50-day average ($2.68) and +18.6% vs its 200-day average ($1.82).
- 52-week range $0.80–$3.44; today's close sits at 52% of that range, 37.2% below the 52-week high.
- That makes 8 straight losses.
STIM latest news & SEC filings
Every SEC filing by or about STIM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 24, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 19, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 18, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chernett Jorey bought 14,000 shares at $3.16 (≈$44.24K) on Aug 14, 2026
- Chernett Jorey bought 14,000 shares at $3.16 (≈$44.24K) on Aug 14, 2026
- Chernett Jorey bought 14,000 shares at $3.16 (≈$44.24K) on Aug 14, 2026
- Chernett Jorey bought 14,000 shares at $3.16 (≈$44.24K) on Aug 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $41.57M (prior year $38.11M) (+9.1% vs Jun 30, 2025)
- Net income: -$3.44M (prior year -$10.12M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 23, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chernett Jorey bought 35,000 shares at $1.78 (≈$62.30K) on Jul 14, 2026
- Chernett Jorey bought 35,000 shares at $1.78 (≈$62.30K) on Jul 14, 2026
- Chernett Jorey bought 35,000 shares at $1.78 (≈$62.30K) on Jul 14, 2026
- Chernett Jorey bought 35,000 shares at $1.78 (≈$62.30K) on Jul 14, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade STIM
- Last results release: Aug 11, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 17, 2026, Feb 10, 2026. Based on that rhythm, the next report is likely around Nov 10, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.87% (largest 7.6%).
- Liquidity: about 779.14K shares (≈$1.47M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.88 vs a range of $0.80–$3.44 (41% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Jorey Chernett bought 14,000 shares on Aug 14, 2026.
- Latest filings: 8-K Aug 17, 2026; 10-Q Aug 11, 2026; 8-K Aug 11, 2026.
- Share count: 76.20M shares outstanding (Aug 5, 2026), +15.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
STIM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.95 | 1.97 | 1.85 | 1.88 | 967.69K |
| Oct 15, 2026 | 1.88 | 1.99 | 1.84 | 1.95 | 768.60K |
| Oct 14, 2026 | 1.95 | 1.97 | 1.88 | 1.88 | 818.20K |
| Oct 13, 2026 | 2.13 | 2.13 | 1.99 | 1.99 | 547.90K |
| Oct 12, 2026 | 2.13 | 2.14 | 2.10 | 2.13 | 329.70K |
| Oct 9, 2026 | 2.14 | 2.20 | 2.11 | 2.13 | 578.70K |
| Oct 8, 2026 | 2.19 | 2.19 | 2.11 | 2.14 | 646.90K |
| Oct 7, 2026 | 2.21 | 2.22 | 2.15 | 2.17 | 641.90K |
| Oct 6, 2026 | 2.22 | 2.28 | 2.19 | 2.21 | 771.80K |
| Oct 5, 2026 | 2.14 | 2.28 | 2.12 | 2.20 | 810.30K |
| Oct 2, 2026 | 2.23 | 2.26 | 2.12 | 2.16 | 1.27M |
| Oct 1, 2026 | 2.38 | 2.38 | 2.20 | 2.22 | 1.31M |
| Sep 30, 2026 | 2.36 | 2.42 | 2.34 | 2.34 | 624.50K |
| Sep 29, 2026 | 2.55 | 2.57 | 2.33 | 2.36 | 1.26M |
| Sep 28, 2026 | 2.70 | 2.71 | 2.54 | 2.56 | 958.90K |
| Sep 25, 2026 | 2.81 | 2.84 | 2.74 | 2.74 | 477.80K |
| Sep 24, 2026 | 2.86 | 2.88 | 2.76 | 2.82 | 590.50K |
| Sep 23, 2026 | 2.88 | 2.92 | 2.83 | 2.88 | 779.70K |
| Sep 22, 2026 | 2.75 | 2.97 | 2.73 | 2.91 | 809.50K |
| Sep 21, 2026 | 2.88 | 2.90 | 2.80 | 2.85 | 623.50K |
About Neuronetics
Neuronetics (STIM) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MALVERN, PA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1227636.
STIM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Avinash Amin | Director | Jun 17, 2026 |
| Robert Cascella | Director | May 29, 2026 |
| Sheryl L Conley | Director | May 29, 2026 |
| Sasha Cucuz | Director | May 29, 2026 |
| Glenn P Muir | Director | May 29, 2026 |
| Megan Rosengarten | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cory Anderson | EVP & Gen. Manager, Greenbrook | Jul 13, 2026 |
| Francis X Iii Brown | Interim PAO | May 13, 2026 |
| William Andrew Macan | EVP, CLO and CS | Mar 24, 2026 |
| Nir Naor | EVP, CFO & Treasurer | Jul 23, 2026 |
| Steven Pfanstiel | Former EVP, CFO and Treasurer | May 21, 2026 |
| Daniel L. Reuvers | President and CEO | Mar 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 14, 2026 | Jorey Chernett | Buy | 14,000 | $3.16 |
| Aug 14, 2026 | Jorey Chernett | Buy | 14,000 | $3.16 |
| Aug 14, 2026 | Jorey Chernett | Buy | 14,000 | $3.16 |
| Aug 14, 2026 | Jorey Chernett | Buy | 14,000 | $3.16 |
| Jul 14, 2026 | Jorey Chernett | Buy | 35,000 | $1.78 |
| Jul 14, 2026 | Jorey Chernett | Buy | 35,000 | $1.78 |
| Jul 14, 2026 | Jorey Chernett | Buy | 35,000 | $1.78 |
| Jul 14, 2026 | Jorey Chernett | Buy | 35,000 | $1.78 |
| May 19, 2026 | Jorey Chernett | Buy | 100,000 | $1.17 |
| May 19, 2026 | Jorey Chernett | Buy | 100,000 | $1.17 |
| May 19, 2026 | Jorey Chernett | Buy | 100,000 | $1.17 |
| May 19, 2026 | Jorey Chernett | Buy | 100,000 | $1.17 |
| May 12, 2026 | Jorey Chernett | Buy | 475,000 | $1.34 |
| May 12, 2026 | Jorey Chernett | Buy | 475,000 | $1.34 |
| May 12, 2026 | Jorey Chernett | Buy | 475,000 | $1.34 |
STIM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $149.16M | $-39.00M | -0.59 | $-20.37M |
| Dec 31, 2024 | $74.89M | $-43.71M | -1.38 | $-31.00M |
| Dec 31, 2023 | $71.35M | $-30.19M | -1.05 | $-32.04M |
| Dec 31, 2022 | $65.21M | $-37.16M | -1.38 | $-30.74M |
| Dec 31, 2021 | $55.31M | $-31.19M | -1.22 | $-27.98M |
Latest balance sheet: total assets $131.53M, total liabilities $109.89M, cash $19.20M (as of Jun 30, 2026).
STIM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $3.19 |
| May 5, 2026 | 8-K Item 2.02 (results) | $2.17 |
| Mar 17, 2026 | 8-K Item 2.02 (results) | $1.23 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $1.46 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $2.87 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $4.55 |
| May 6, 2025 | 8-K Item 2.02 (results) | $4.50 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $5.06 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $2.34 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $0.69 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on STIM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.